Indivior Pharmaceuticals, Inc. (SUPN) EBITDA
- 2026-06-30: Basis Reported; EBITDA $162.00M*; Operating income $160.00M; Depreciation and amortization $2.00M*.
- 2026-03-31: Basis Reported; EBITDA $17.8M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA $21.08M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA $46.00M*; Operating income $43.00M; Depreciation and amortization $3.00M*.
Complete source-backed ebitda history.
- Available history
- 2010-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | $162.00M* | $160.00M | $2.00M* | $343.00M | 47.23%* | $7.00M* | $229.00M* | $50.00M | (m) | $122.00M | $38.00M |
|---|
| 2026-03-31 | Reported | $17.8M | (m) | (m) | (m) | 8.57% | $20.00M | -$9.00M | $40.00M | (m) | $124.00M | $26.00M |
|---|
| 2025-12-31 | Reported | $21.08M | (m) | (m) | (m) | 9.96% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | $46.00M* | $43.00M | $3.00M* | $314.00M | 14.65%* | $20.00M* | -$39.00M* | $83.00M | (m) | $155.00M | -$5.00M |
|---|
| 2025-06-30 | Reported | $74.00M* | $72.00M | $2.00M* | $302.00M | 24.50%* | $17.00M* | $158.00M* | $52.00M | (m) | $158.00M | $44.00M |
|---|
| 2025-03-31 | Reported | $10.13M | (m) | (m) | (m) | 6.76% | $5.00M | $75.00M | $44.00M | (m) | $133.00M | $11.00M |
|---|
| 2024-12-31 | Reported | $40.25M | (m) | (m) | (m) | 23.11% | (m) | (m) | (m) | (m) | $175.00M | $17.00M |
|---|
| 2024-09-30 | Reported | $39.00M* | $35.00M | $4.00M* | $307.00M | 12.70%* | $7.00M* | $2.00M* | $66.00M | (m) | $142.00M | $8.00M |
|---|
| 2024-06-30 | Reported | -$116.00M* | -$118.00M | $2.00M* | $299.00M | -38.80%* | $4.00M* | $88.00M* | $79.00M | (m) | $152.00M | -$23.00M |
|---|
| 2024-03-31 | Reported | $17.6M | (m) | (m) | (m) | 12.25% | $2.00M | -$37.00M | $38.00M | (m) | $143.00M | $11.00M |
|---|
| 2023-12-31 | Reported | $20.68M | (m) | (m) | (m) | 12.59% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-03-31 | Reported | $25.78M | (m) | (m) | (m) | 16.76% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-12-31 | Reported | $55.18M | (m) | (m) | (m) | 32.98% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-03-31 | Reported | $23.33M | (m) | (m) | (m) | 15.30% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-12-31 | Reported | $18.81M | (m) | (m) | (m) | 11.82% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-03-31 | Reported | $19.81M | (m) | (m) | (m) | 15.13% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-12-31 | Reported | $48.52M | (m) | (m) | (m) | 33.80% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-03-31 | Reported | $30.74M | (m) | (m) | (m) | 32.37% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2019-12-31 | Reported | $42.45M | (m) | (m) | (m) | 42.26% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2019-03-31 | Reported | $27.11M | (m) | (m) | (m) | 31.71% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2018-12-31 | Reported | $41.55M | (m) | (m) | (m) | 35.84% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2018-03-31 | Reported | $33.1M | (m) | (m) | (m) | 36.60% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2017-12-31 | Reported | $36.01M | (m) | (m) | (m) | 41.71% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2017-03-31 | Reported | $17.53M | (m) | (m) | (m) | 31.10% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2016-12-31 | Reported | $16.97M | (m) | (m) | (m) | 27.77% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2016-03-31 | Reported | $6.87M | (m) | (m) | (m) | 15.96% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2015-12-31 | Reported | $8.15M | (m) | (m) | (m) | 19.13% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2015-03-31 | Reported | $3.64M | (m) | (m) | (m) | 12.97% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2014-12-31 | Reported | -$24.55M | (m) | (m) | (m) | -80.46% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2014-03-31 | Reported | -$13.2M | (m) | (m) | (m) | -146.69% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2013-12-31 | Reported | -$11.14M | (m) | (m) | (m) | -108.49% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2013-03-31 | Reported | -$17.75M | (m) | (m) | (m) | -12072.11% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2012-12-31 | Reported | -$12.52M | (m) | (m) | (m) | -1149.86% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2012-03-31 | Reported | -$7.65M | (m) | (m) | (m) | -3679.33% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2011-12-31 | Reported | -$10.02M | (m) | (m) | (m) | -23847.62% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2011-03-31 | Reported | -$8.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | $29.28M | (m) | (m) | (m) | 4.07% | $66.00M | -$27.00M | $246.00M | (m) | $634.00M | $29.00M |
|---|
| 2025-09-30 | Rolling | (m) | $227.00M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $621.00M* | $67.00M* |
|---|
| 2025-06-30 | Rolling | (m) | $219.00M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $608.00M* | $80.00M* |
|---|
| 2025-03-31 | Rolling | (m) | $29.00M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $602.00M* | $13.00M* |
|---|
| 2024-12-31 | Reported | $162.08M | (m) | (m) | (m) | 24.49% | $29.00M | $36.00M | $231.00M | (m) | $612.00M | $13.00M |
|---|
| 2024-12-31 | Rolling | (m) | $38.00M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $612.00M* | $13.00M* |
|---|
| 2023-12-31 | Reported | $79.59M | (m) | (m) | (m) | 13.10% | $8.00M | -$300.00M | $174.00M | (m) | $565.00M | -$19.00M |
|---|
| 2022-12-31 | Reported | $131.67M | (m) | (m) | (m) | 19.73% | $5.00M | -$4.00M | $151.00M | (m) | $466.00M | -$43.00M |
|---|
| 2021-12-31 | Reported | $118.62M | (m) | (m) | (m) | 20.46% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-12-31 | Reported | $191.84M | (m) | (m) | (m) | 36.86% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2019-12-31 | Reported | $155.23M | (m) | (m) | (m) | 39.52% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2018-12-31 | Reported | $151.51M | (m) | (m) | (m) | 37.05% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2017-12-31 | Reported | $107.67M | (m) | (m) | (m) | 36.61% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2016-12-31 | Reported | $56.62M | (m) | (m) | (m) | 26.95% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2015-12-31 | Reported | $21.77M | (m) | (m) | (m) | 15.16% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2014-12-31 | Reported | -$4.35M | (m) | (m) | (m) | -4.86% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2013-12-31 | Reported | -$61.18M | (m) | (m) | (m) | -529.59% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2012-12-31 | Reported | -$41.3M | (m) | (m) | (m) | -2790.41% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2011-12-31 | Reported | -$36.87M | (m) | (m) | (m) | -4591.91% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2010-12-31 | Reported | -$38.94M | (m) | (m) | (m) | -36731.13% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|